Clinical Trial Update: Pharmacokinetics of BIA 5-453 and Its Metabolites [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of BIA 5-453 and its metabolites, summarizing pharmacokinetic profiles relevant to hypertension and chronic heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension

Drugs mentioned

• BIA 5-453

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Hypertension, Chronic Heart Failure | Phase 1 | Status: COMPLETED